NCT02124083 |
|
Phase 12 Study of Vorinostat Therapy in Niemann-Pick Disease Type C1
|
View
|
NCT02939547 |
|
Study of the Pharmacokinetics of Trappsol and Effects on Potential Biomarkers of Niemann-Pick C1 NPC1
|
View
|
NCT05642221 |
|
Functional Near-Infrared Spectroscopy fNIRS Combined With Diffuse Correlation Spectroscopy DCS in Neurocognitive Disease as Compared to Healthy Neurotypical Controls
|
View
|
NCT02435030 |
|
A Prospective Non-therapeutic Study in Patients Diagnosed With Niemann-Pick Disease Type C
|
View
|
NCT01747135 |
|
Hydroxypropyl Beta Cyclodextrin for Niemann-Pick Type C1 Disease
|
View
|
NCT04958642 |
|
Adrabetadex to Treat Niemann-Pick Type C1 NPC1 Disease
|
View
|
NCT03643562 |
|
Niemann-Pick Type C Treatment With Adrabetadex for Symptoms of Brain and Nervous System
|
View
|
NCT04860960 |
|
Phase 3 Study to Evaluate Intravenous TrappsolR CycloTM in Pediatric and Adult Patients With Niemann-Pick Disease Type C1
|
View
|
NCT03879655 |
|
Open-label Study of VTS-270 in Participants With Neurologic Manifestations of Niemann-Pick Type C1
|
View
|
NCT02534844 |
|
VTS-270 to Treat Niemann-Pick Type C1 NPC1 Disease
|
View
|
NCT02612129 |
|
Arimoclomol Prospective Study in Participants Diagnosed With Niemann-Pick Disease Type C
|
View
|
NCT03471143 |
|
Study of IV VTS-270 for Infantile Liver Disease Associated With Niemann-Pick Disease Type C
|
View
|
NCT03887533 |
|
Combined Intrathecal and Intravenous VTS-270 Therapy for Liver and Neurological Disease Associated With Niemann-Pick Disease Type C1
|
View
|